32.6 C
Delhi
Wednesday, June 4, 2025

Dr Reddy Labs launches Lenalidomide Capsules in US

Date:

Share post:

Donate-GC-Razorpay

Mumbai: Dr. Reddy’s Labs on Thursday announced the launch of Lenalidomide Capsules in the US market, , a therapeutic equivalent generic version of REVLIMID (lenalidomide) Capsules approved by U. S. Food and Drug Administration (USFDA).

With this volume-limited launch, Dr. Reddy’s is eligible for first-to-market, 180 days of generic drug exclusivity for Lenalidomide Capsules in 2.5 mg and 20 mg strengths.

‘We are pleased with the first-to-market launch of two of our six strengths of Lenalidomide Capsules with 180-day market exclusivity,” says Marc Kikuchi, CEO, North America Generics, Dr. Reddy’s Laboratories.

“Bringing a more affordable generic version to market creates greater patient access for this important drug.’

Dr. Reddy’s Lenalidomide Capsules are available in strengths of 2.5 mg, 5 mg, and 10 mg, each in a bottle-count size of 28, as well as 15 mg, 20 mg, and 25 mg strengths, each in a bottle-count size of 21.

Related articles

India Rarely Wins the Narrative War – And That’s a National Security Failure

India is a nation of unmatched civilizational legacy, technological prowess, and military strength. Yet, when it comes to...

RCB’s historic victory parade in Bengaluru today

Bengaluru: After 18 long years of waiting, hope, heartbreak, and unyielding fan loyalty, Bengaluru is all set to...

Americans are spending less due to Trump tariffs: report

London: Americans are planning to spend less money this summer due to the impact of U.S. President Donald...

SL to import 18,000 metric tons of maize to ensure nutritional supplement

Colombo: Sri Lanka's Cabinet of Ministers has authorized Sri Lanka Thriposha Limited Company to import 18,000 metric tons...